The potential role of emicizumab prophylaxis in severe von Willebrand disease
Blood Cells, Molecules, and Diseases · 2021-03 · 87 · 102530
DOI: 10.1016/j.bcmd.2020.102530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2021-03. Verfasst von Assaf A Barg und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School …. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Roche.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel.
- Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel.
- National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: gili.ken…
Förderung
- Roche
Zitieren
APA
Barg, A. A., Avishai, E., Budnik, I., Brutman, T. B., Tamarin, I., Dardik, R., Bashari, D., Misgav, M., Lubetsky, A., Lalezari, S., Livnat, T., & Kenet, G. (2021). The potential role of emicizumab prophylaxis in severe von Willebrand disease. Blood Cells, Molecules, and Diseases, 87, 102530. https://doi.org/10.1016/j.bcmd.2020.102530
Vancouver
Barg AA, Avishai E, Budnik I, Brutman TB, Tamarin I, Dardik R, et al. The potential role of emicizumab prophylaxis in severe von Willebrand disease. Blood Cells, Molecules, and Diseases. 2021;87:102530. doi:10.1016/j.bcmd.2020.102530
BibTeX
@article{Barg2021,
author = {Barg, Assaf A and Avishai, Einat and Budnik, Ivan and Brutman, Tamar Barazani and Tamarin, Ilia and Dardik, Rima and Bashari, Dalia and Misgav, Mudi and Lubetsky, Aharon and Lalezari, Shadan and Livnat, Tami and Kenet, Gili},
title = {The potential role of emicizumab prophylaxis in severe von Willebrand disease},
journal = {Blood Cells, Molecules, and Diseases},
year = {2021},
volume = {87},
pages = {102530},
doi = {10.1016/j.bcmd.2020.102530}
}
EUVIMED